Trade Summary

2 days ago, MALCOLM JAN, serving as Dir at UNITED THERAPEUTICS Corp (UTHR), sold 325 shares at $550.59 per share, for a total transaction value of $178,941.75. Following this transaction, MALCOLM JAN now holds 450 shares of UTHR.

This sale represents a 41.94% decrease in MALCOLM JAN's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, July 10, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 10, 2026 at 4:02 PM ET, meaning the disclosure happened on the same day as the trade.

UNITED THERAPEUTICS Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.